Sanara MedTech (SMTI) Income towards Parent Company (2010 - 2026)

Sanara MedTech has reported Income towards Parent Company for 16 years, with the latest figure at $60916.0 in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company rose 102.1% year-over-year to $60916.0; the trailing twelve-month figure through Mar 2026 stood at -$33.5 million (down 184.63% YoY), and the FY2025 full-year result was -$37.2 million, down 366.18% from the prior year.
• Income towards Parent Company for Q1 2026 stood at $60916.0, up from -$502848.0 in the prior quarter.
• The five-year high for Income towards Parent Company was $756914.0 in Q2 2022, with the low at -$31.2 million in Q3 2025.
• Historically, Income towards Parent Company has averaged -$3.5 million across 5 years, with a median of -$1.8 million in 2025.
• Annual changes were most pronounced in 2022 — Income towards Parent Company soared 173.76% — and 2025, when it sank 1056.18%.
• Sanara MedTech's Income towards Parent Company stood at -$4.2 million in 2022, then soared by 93.76% to -$262444.0 in 2023, then plunged by 904.14% to -$2.6 million in 2024, then surged by 80.92% to -$502848.0 in 2025, then soared by 112.11% to $60916.0 in 2026.
• The last three Income towards Parent Company figures came in at $60916.0 (Q1 2026), -$502848.0 (Q4 2025), and -$31.2 million (Q3 2025), per Business Quant data.